Epigenome-wide association study of leukocyte telomere length
- PMID: 31461406
- PMCID: PMC6738430
- DOI: 10.18632/aging.102230
Epigenome-wide association study of leukocyte telomere length
Abstract
Telomere length is associated with age-related diseases and is highly heritable. It is unclear, however, to what extent epigenetic modifications are associated with leukocyte telomere length (LTL). In this study, we conducted a large-scale epigenome-wide association study (EWAS) of LTL using seven large cohorts (n=5,713) - the Framingham Heart Study, the Jackson Heart Study, the Women's Health Initiative, the Bogalusa Heart Study, the Lothian Birth Cohorts of 1921 and 1936, and the Longitudinal Study of Aging Danish Twins. Our stratified analysis suggests that EWAS findings for women of African ancestry may be distinct from those of three other groups: males of African ancestry, and males and females of European ancestry. Using a meta-analysis framework, we identified DNA methylation (DNAm) levels at 823 CpG sites to be significantly associated (P<1E-7) with LTL after adjusting for age, sex, ethnicity, and imputed white blood cell counts. Functional enrichment analyses revealed that these CpG sites are near genes that play a role in circadian rhythm, blood coagulation, and wound healing. Weighted correlation network analysis identified four co-methylation modules associated with LTL, age, and blood cell counts. Overall, this study reveals highly significant relationships between two hallmarks of aging: telomere biology and epigenetic changes.
Keywords: DNA methylation; leukocyte telomere length; multi-ancestry.
Conflict of interest statement
Figures






References
-
- Yui J, Chiu CP, Lansdorp PM. Telomerase activity in candidate stem cells from fetal liver and adult bone marrow. Blood. 1998; 91:3255–62. - PubMed
Publication types
MeSH terms
Grants and funding
- R03 AG060619/AG/NIA NIH HHS/United States
- R01 AG016592/AG/NIA NIH HHS/United States
- HHSN268201800014C/HL/NHLBI NIH HHS/United States
- MR/M01311/1/MRC_/Medical Research Council/United Kingdom
- HHSN268201800011C/HL/NHLBI NIH HHS/United States
- HHSN268201600001C/HL/NHLBI NIH HHS/United States
- HHSN268201800015I/HB/NHLBI NIH HHS/United States
- WT_/Wellcome Trust/United Kingdom
- HHSN268201800011I/HB/NHLBI NIH HHS/United States
- MR/K026992/1/MRC_/Medical Research Council/United Kingdom
- HHSN268201800012C/HL/NHLBI NIH HHS/United States
- U01 AG060908/AG/NIA NIH HHS/United States
- HHSN268201600002C/HL/NHLBI NIH HHS/United States
- HHSN268201500001C/HL/NHLBI NIH HHS/United States
- HHSN268201600018C/HL/NHLBI NIH HHS/United States
- HHSN268201800014I/HB/NHLBI NIH HHS/United States
- N01 HC025195/HL/NHLBI NIH HHS/United States
- HHSN268201800013I/MD/NIMHD NIH HHS/United States
- HHSN268201600003C/HL/NHLBI NIH HHS/United States
- R01 AG029451/AG/NIA NIH HHS/United States
- HHSN268201500001I/HL/NHLBI NIH HHS/United States
- HHSN268201800012I/HL/NHLBI NIH HHS/United States
- P01 AG008761/AG/NIA NIH HHS/United States
- HHSN268201600004C/HL/NHLBI NIH HHS/United States
- HHSN268201800010I/HB/NHLBI NIH HHS/United States
- BB/F019394/1/BB_/Biotechnology and Biological Sciences Research Council/United Kingdom
- U54 GM115428/GM/NIGMS NIH HHS/United States
- R01 HL134840/HL/NHLBI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical